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The coating of implantable nano- or micro-objects with polyethylene glycol (PEG) enhances its
biocompatibility and biodistribution. Herein, we describe a new protocol that enhances and maintains
MNPs stability in biological media, simulating multiple conditions to which they would be subjected in
the human body. Magnetite nanoparticles (MNPs) prepared via a facile way at room temperature by co-
precipitation reaction, were coated with dicarboxylic polyethylene glycol (DCPEG) via covalent bonds.
The surface of the nanoparticles was ﬁrst coated with 3-aminopropyl trimethoxysilane by a silanization
reaction and then linked with DCPEG of different molecular weight (Mw¼5000, 10,000 and
20,000 g mol−1). The uncoated magnetite nanoparticles, with an average size of 20 nm, exhibited
superparamagnetism, high saturation magnetization and a negative surface charge (with a zeta potential
value of −40 mV). Increase of Mw enhances the colloidal stability of MNPs and makes them more
suitable to tolerate high salt concentrations (1M NaCl) and wide pH (from 5.5 to 12) and temperature
ranges (24 1C to 46 1C). The results indicate that magnetite nanoparticles coated with DCPEG with
Mw¼20,000 have improved properties over their counterparts, making them our best choice for
biomedical studies.
& 2013 Elsevier B.V. All rights reserved.1. Introduction
The stability of magnetic nanoparticles (MNPs) in aqueous
media results from the equilibrium established between attractive
and repulsive forces. Attractive forces come from van der Waals
and magnetic dipolar attractions, while repulsive forces mainly
originate from electrostatic and steric repulsions [1]. In aqueous
solutions, the Fe atoms coordinate with water, which dissociates
readily to leave the iron oxide surface hydroxyl functionalized.
These hydroxyl groups are amphoteric and may react with acids
and bases [2]. Depending upon the pH of the solution, the surface
of the magnetite will be positively or negatively charged. For
superparamagnetic iron oxide nanoparticles (SPIONs) to be stable
in aqueous media at physiological pH (7.35–7.45 for human blood),
it is necessary to bring in additional charges to the nanoparticle
surface. This is very important for electrostatically stabilizing the
colloids due to the fact that the isoelectric point (IEP) of “naked”
SPIONs is observed at pH 6.8 [3]. Around this point of zero chargell rights reserved.
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.(PZC), the surface charge density is too small and the particles
are no longer stable in water and ﬂocculate. Matching both
electrostatic and steric stabilization, allows to obtain stable SPIONs
[4–6].
Nevertheless, satisfying colloidal stability around neutral pH is
not enough for magnetic nanoparticles to be useful as magnetic-
ﬁeld-directed drug targeting and as contrast agents for magnetic
resonance imaging administrated intravenously; they should also
have good enough colloidal stability at physiological ionic strength
around 0.17 M. Phosphate buffered saline (PBS) is often used to
mimic the pH and ionic strength of physiological conditions as the
osmolarity and ion concentrations of the PBS buffer match those of
the human body [1]. However, in biological media, electrostatically
stable MNPs are prone to aggregation due to neutralization of the
surface charge [7]. Therefore, polymers are often used as stabiliz-
ing agents as they provide steric repulsion to the MNPs in addition
to electrostatic repulsion, thus being able to reduce the inﬂuence
of ionic strength on the colloidal stability.
Under physiological conditions, the effective minimization of
SPIONs aggregation, caused by protein adsorption, must also be
taken into account. Thus, anti-biofouling polymers are preferred to
modify the MNPs for producing reticuloendothelial system evad-
ing nanoparticles with long blood half-lifes [8]. Among anti-
biofouling polymers, polyethylene glycol (PEG) is one of the good
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particles present long blood circulation time [9].
Dicarboxyl-terminated PEG (HOOC-PEG-COOH), DCPEG, was
adopted as the nanoparticle surface capping agent for providing
the magnetic nanoparticle biocompatibility, meanwhile offering
free surface carboxylic acid groups for further covalently conjugat-
ing the Fe3O4 nanoparticles to bioligands bearing amine groups,
via the EDC/NHS mediated amidation reaction [10–14]. It has been
demonstrated that Fe3O4 nanoparticles coated by dicarboxyl-
terminated poly(ethylene glycol) (HOOC-PEG-COOH) can be used
for constructing MRI dual modality molecular probes for in vivo
colorectal carcinoma and gastric carcinoma detection [10,15,16].
Herein, we study the important effect of the molecular weight of
DCPEG on the colloidal stability of magnetite nanoparticles, and
present a new surface engineering approach that produces a
highly stable polymeric coating and MNPs.2. Experimental section
Preparation of DCPEG–Fe3O4MNPs: All the reagents used in this
work were analytical grade without further puriﬁcation. Iron (III)
chloride hexahydrate (FeCl3.6H2O, ≥99%), iron (II) chloride tetra-
hydrate (FeCl2.4H2O, 99%), ammonium hydroxide (NH4OH, 33%
NH3 in H2O) were obtained from Sigma. DCPEG5000 (Mw≈
4900 g mol−1—Figure S1 of Supporting Information), DCPEG10000
(Mw≈11,400 g mol−1—Figure S2 of Supporting Information),
DCPEG20000 (Mw≈20,000 g mol−1) were all purchased from Nano
OcS. (3-aminopropyl) triethoxysilane (APTES) was a coupling
agent from Sigma. N-(3-dimethylaminopropyl)-N′-ethylcarbodii-
mide hydrochloride (EDC, ≥98%) and N-hydroxysuccinimide (NHS)Fig. 1. (A) Evolution of hydrodynamic size with the increasing Mw of DCPEG (a: results
with the increasing Mw of DCPEG (a: results from the work, c: results from [18]). TEMwere bought from Sigma. In all experiments, deionized water
was used.
The procedure used for the preparation of MNPs and coating by
silanization reaction was based on a previously described protocol
[17]. The magnetite (Fe3O4) nanoparticles were synthesized by the
co-precipitation reaction of ferrous and ferric salts with NH4OH
acting as a reducing agent. Then the MNPs were coated with
APTES and ﬁnally linked with dicarboxyl-terminated DCPEG via
the EDC/NHS reaction between –NH2 and –COOH to form well-
dispersed surface functionalized biocompatible MNPs.
Characterization: The morphology of Fe3O4 and DCPEG–Fe3O4
was observed using a Philips CM-12 transmission electron micro-
scope (TEM) operating at an acceleration voltage of 100 kV.
Samples for TEM were obtained by the evaporation of a drop of
the solution sample (C¼1 mg mL−1) on a carbon-coated copper
grid (400 mesh), under ambient conditions. Later the images were
analyzed by Image J software (NIH). The dynamic light scattering
(DLS) and zeta (ζ) potential measurements were performed with a
Nano-ZS, Malvern Zetasizer. Ultrasonic dispersion was performed
for 15 min for each sample before DLS and ζ potential measure-
ments. All measurements were repeated three times. Magnetic
properties were measured on a vibrating sample magnetometer
(VSM) (PPMS, Quantum Design) at 25 1C in a ﬁeld up to 100 kOe.
Mass spectroscopy measurements (MALDI-TOF) were carried out
using a ULTRAFLEX III TOF/TOF (BRUKER).3. Results and discussion
Fig. 1A presents the average size of MNPs coupled with DCPEG
with Mw of 5000, 10,000 and 20,000 g mol−1, in aqueous medium
obtained by DLS. Before modiﬁcation the MNPs exhibit an averagefrom the work, b: results from [18], c: results from [17]). (B) Evolution of ζ potential
images of (C) Fe3O4 and (D) DCPEG–Fe3O4.
Fig. 3. Evolution of ζ potential measurements with (A) temperature and (B) pH
(a: Fe3O4, b: DCPEG5000–Fe3O4, c: DCPEG10,000−Fe3O4, d: DCPEG20,000–Fe3O4).
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size increases with the increasing length of DCPEG chains from
110 nm up to around 120 nm. Both Xie et al. [18] and Feng et al.
[17] also found a similar behavior—see comparison in Fig. 1A.
ζ potential measurements show that before the modiﬁcation the
MNPs are stable (|ζ|≥25 mV) and negatively charged. However,
when coated with DCPEG, the MNPs exhibit a positively charged ζ
potential that remains positive regardless of DCPEG Mw (Fig. 1B).
The positive ζ potential can be explained by the hydration of
polymer coating surrounding the magnetite core, which increases
steric repulsion. Another factor is that not all the –NH2 groups in
APTES react with DCPEG and, in culture medium, these groups can
exist in a cationic form.
TEM images show that both Fe3O4 (Fig. 1C) and DCPEG-Fe3O4
(Fig. 1D) MNPs present spherical shape and a core size of
14.872.9 nm and 13.873.4 nm, respectively. The low contrast of
the organic coating explains the similarity of these values.
For clinical purposes it is important that DCPEG–Fe3O4 MNPs
maintain the same magnetic properties as before the modiﬁcation.
Both Fe3O4 and DCPEG–Fe3O4 MNPs show a superparamagnetic
behavior at room temperature, with negligible hysteresis and rema-
nence (MR(Fe3O4)¼1.19 emu g−1 and MR(DCPEG10000–Fe3O4)¼
0.93 emu.g−1)—Fig. 2. The saturation magnetization of the samples is
70.0 emu g−1 (iron oxide) for the Fe3O4 and 67.9 emu.g−1 for the
DCPEG–Fe3O4. Thereby it becomes possible to conclude that the
magnetite core remains intact and the magnetic properties were kept.
Stability of the PEG coated nanoparticles was tested by mea-
suring the ζ potential through a range of temperatures. Fig. 3A
shows that uncoated MNPs exhibit a negative potential whereas,
when coated with DCPEG, the MNPs' potential increases with
increasing Mw. In all cases no signiﬁcant changes of ζ potential
were noticed with temperature indicating that DCPEG offers a
stable coating to the MNPs.
To study the effects of pH and ionic strength on colloidal
stability, MNPs were exposed to a range of pHs from 2 to 12 and
to different NaCl concentrations (from 0 to 1 M). Fig. 3B shows that
the MNPs coated with DCPEG20000 are more stable in pHs ranging
from 9–12 and 2–4, and the ones coated with DCPEG5000 reveal
more stability for basic pHs. The size distribution shown in Fig. 4
demonstrates that the MNPs size remains almost unchanged at
NaCl concentrations as high as 1 M proving that the inﬂuence of
ionic strength on the colloidal stability can effectively be reducedFig. 2. Magnetization curves obtained by VSM at room temperature of Fe3O4 and
DCPEG10,000–Fe3O4 MNPs. (A) Scale from −10 kOe to 10 kOe and (B) Scale from
−1 kOe to 1 kOe.with the DCPEG20000 coating. In the literature there are calcula-
tions that estimate the maximum chain length of DCPEG20000 as
being 200 nm [19]. Thereby, in Fig. 4 it is observed that the
distribution peak is always below 200 nm, except for graphs B
and C, in which the distribution is not as narrower as for the other
concentrations, and a second peak appears indicating that for
0.001 M and 0.1 M concentrations, some aggregation must be
present. For the DCPEG5000 (see supporting information) it was
found that the MNPs were not stable for concentrations below
0.1 M.4. Conclusions
In summary, biocompatible, water-soluble DCPEG-Fe3O4 MNPs
of varying size were synthesized by surface modiﬁcation of the
Fe3O4 core by silanization reaction. MNPs colloidal stability was
evaluated based on DLS and ζ potential measurements performed
at room temperature. We concluded that DCPEG has an important
effect on size, and charge properties of the MNPs. Among the
different formulations tested, DCPEG20000–Fe3O4 MNPs kept the
morphology of Fe3O4 core and showed colloidal stability, with
non-detectable aggregation, when exposed to different salt con-
centration, pH and temperature. This, plus the multiple free
carboxylic groups present on the nanoparticles surface makes
DCPEG–Fe3O4 MNPs suitable for enhancing contrast in MRI and
for drug delivery purposes.
Fig. 4. Distribution of hydrodynamic sizes of DCPEG20000–Fe3O4 MNPs incubated in NaCl solution with different concentrations (A: 510−4 M, B: 0.001 M, C: 0.1 M, D: 0.5 M,
E: 1 M).
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